vs
美盛公司（MOS）与Ventas（VTR）财务数据对比。点击上方公司名可切换其他公司
美盛公司的季度营收约是Ventas的1.8倍（$3.0B vs $1.7B），Ventas净利率更高（3.6% vs -17.5%，领先21.0%），Ventas同比增速更快（22.0% vs 5.6%），过去两年Ventas的营收复合增速更高（17.5% vs 5.3%）
美盛公司（The Mosaic Company）是总部位于美国佛罗里达州坦帕的化工企业，主营磷矿、钾矿开采及尿素采集，依托多元国际分销网络和旗下肥料业务板块生产销售农用肥料，是美国规模最大的钾肥、磷肥生产商。
Ventas是一家领先的医疗地产投资信托企业，旗下资产涵盖养老社区、医疗办公楼、生命科学研究设施及康复医疗中心等，主要在北美、英国地区运营，为医疗服务及生命科学机构提供专业物业解决方案。
MOS vs VTR — 直观对比
营收规模更大
MOS
是对方的1.8倍
$1.7B
营收增速更快
VTR
高出16.4%
5.6%
净利率更高
VTR
高出21.0%
-17.5%
两年增速更快
VTR
近两年复合增速
5.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.0B | $1.7B |
| 净利润 | $-519.5M | $59.0M |
| 毛利率 | 11.5% | — |
| 营业利润率 | -3.4% | — |
| 净利率 | -17.5% | 3.6% |
| 营收同比 | 5.6% | 22.0% |
| 净利润同比 | -407.4% | 19.0% |
| 每股收益（稀释后） | $-1.63 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MOSVTR
| Q1 26 | — | $1.7B | ||
| Q4 25 | $3.0B | $1.6B | ||
| Q3 25 | $3.5B | $1.5B | ||
| Q2 25 | $3.0B | $1.4B | ||
| Q1 25 | $2.6B | $1.4B | ||
| Q4 24 | $2.8B | $1.3B | ||
| Q3 24 | $2.8B | $1.2B | ||
| Q2 24 | $2.8B | $1.2B |
净利润MOSVTR
| Q1 26 | — | $59.0M | ||
| Q4 25 | $-519.5M | $73.0M | ||
| Q3 25 | $411.4M | $68.7M | ||
| Q2 25 | $410.7M | $71.5M | ||
| Q1 25 | $238.1M | $48.4M | ||
| Q4 24 | $169.0M | $58.7M | ||
| Q3 24 | $122.2M | $21.0M | ||
| Q2 24 | $-161.5M | $21.2M |
毛利率MOSVTR
| Q1 26 | — | — | ||
| Q4 25 | 11.5% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 17.3% | — | ||
| Q1 25 | 18.6% | — | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 14.8% | — | ||
| Q2 24 | 14.0% | — |
营业利润率MOSVTR
| Q1 26 | — | — | ||
| Q4 25 | -3.4% | 4.9% | ||
| Q3 25 | 9.8% | 3.0% | ||
| Q2 25 | 8.1% | 3.0% | ||
| Q1 25 | 12.9% | 3.0% | ||
| Q4 24 | 3.5% | -0.0% | ||
| Q3 24 | 4.1% | 1.5% | ||
| Q2 24 | 8.3% | -1.6% |
净利率MOSVTR
| Q1 26 | — | 3.6% | ||
| Q4 25 | -17.5% | 4.7% | ||
| Q3 25 | 11.9% | 4.6% | ||
| Q2 25 | 13.7% | 5.0% | ||
| Q1 25 | 9.1% | 3.6% | ||
| Q4 24 | 6.0% | 4.6% | ||
| Q3 24 | 4.3% | 1.7% | ||
| Q2 24 | -5.7% | 1.8% |
每股收益（稀释后）MOSVTR
| Q1 26 | — | — | ||
| Q4 25 | $-1.63 | $0.15 | ||
| Q3 25 | $1.29 | $0.14 | ||
| Q2 25 | $1.29 | $0.15 | ||
| Q1 25 | $0.75 | $0.10 | ||
| Q4 24 | $0.53 | $0.13 | ||
| Q3 24 | $0.38 | $0.05 | ||
| Q2 24 | $-0.50 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $276.6M | $183.6M |
| 总债务越低越好 | $4.3B | — |
| 股东权益账面价值 | $12.1B | $13.2B |
| 总资产 | $24.5B | $27.7B |
| 负债/权益比越低杠杆越低 | 0.35× | — |
8季度趋势，按日历期对齐
现金及短期投资MOSVTR
| Q1 26 | — | $183.6M | ||
| Q4 25 | $276.6M | $741.1M | ||
| Q3 25 | $153.3M | $188.6M | ||
| Q2 25 | $286.2M | $614.2M | ||
| Q1 25 | $259.2M | $182.3M | ||
| Q4 24 | $272.8M | $897.9M | ||
| Q3 24 | $301.6M | $1.1B | ||
| Q2 24 | $322.0M | $557.1M |
总债务MOSVTR
| Q1 26 | — | — | ||
| Q4 25 | $4.3B | $13.0B | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.3B | — | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.3B | $13.5B | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.2B | — |
股东权益MOSVTR
| Q1 26 | — | $13.2B | ||
| Q4 25 | $12.1B | $12.5B | ||
| Q3 25 | $12.8B | $12.4B | ||
| Q2 25 | $12.4B | $11.5B | ||
| Q1 25 | $11.8B | $11.5B | ||
| Q4 24 | $11.5B | $10.8B | ||
| Q3 24 | $11.8B | $9.8B | ||
| Q2 24 | $11.7B | $9.6B |
总资产MOSVTR
| Q1 26 | — | $27.7B | ||
| Q4 25 | $24.5B | $27.6B | ||
| Q3 25 | $24.7B | $26.9B | ||
| Q2 25 | $24.3B | $26.5B | ||
| Q1 25 | $23.2B | $26.0B | ||
| Q4 24 | $22.9B | $26.2B | ||
| Q3 24 | $23.3B | $25.3B | ||
| Q2 24 | $22.6B | $24.5B |
负债/权益比MOSVTR
| Q1 26 | — | — | ||
| Q4 25 | 0.35× | 1.04× | ||
| Q3 25 | 0.26× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.28× | — | ||
| Q4 24 | 0.29× | 1.26× | ||
| Q3 24 | 0.27× | — | ||
| Q2 24 | 0.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-56.1M | — |
| 自由现金流经营现金流 - 资本支出 | $-405.7M | — |
| 自由现金流率自由现金流/营收 | -13.6% | — |
| 资本支出强度资本支出/营收 | 11.8% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-534.6M | — |
8季度趋势，按日历期对齐
经营现金流MOSVTR
| Q1 26 | — | — | ||
| Q4 25 | $-56.1M | $471.7M | ||
| Q3 25 | $228.5M | $378.6M | ||
| Q2 25 | $609.5M | $475.3M | ||
| Q1 25 | $42.9M | $321.1M | ||
| Q4 24 | $219.3M | $373.6M | ||
| Q3 24 | $312.9M | $353.7M | ||
| Q2 24 | $847.0M | $335.9M |
自由现金流MOSVTR
| Q1 26 | — | — | ||
| Q4 25 | $-405.7M | — | ||
| Q3 25 | $-135.9M | — | ||
| Q2 25 | $304.9M | — | ||
| Q1 25 | $-297.9M | — | ||
| Q4 24 | $-74.8M | — | ||
| Q3 24 | $72.1M | — | ||
| Q2 24 | $513.1M | — |
自由现金流率MOSVTR
| Q1 26 | — | — | ||
| Q4 25 | -13.6% | — | ||
| Q3 25 | -3.9% | — | ||
| Q2 25 | 10.1% | — | ||
| Q1 25 | -11.4% | — | ||
| Q4 24 | -2.7% | — | ||
| Q3 24 | 2.6% | — | ||
| Q2 24 | 18.2% | — |
资本支出强度MOSVTR
| Q1 26 | — | — | ||
| Q4 25 | 11.8% | — | ||
| Q3 25 | 10.6% | — | ||
| Q2 25 | 10.1% | — | ||
| Q1 25 | 13.0% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 8.6% | — | ||
| Q2 24 | 11.9% | — |
现金转化率MOSVTR
| Q1 26 | — | — | ||
| Q4 25 | — | 6.46× | ||
| Q3 25 | 0.56× | 5.51× | ||
| Q2 25 | 1.48× | 6.65× | ||
| Q1 25 | 0.18× | 6.64× | ||
| Q4 24 | 1.30× | 6.36× | ||
| Q3 24 | 2.56× | 16.84× | ||
| Q2 24 | — | 15.87× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MOS
暂无分部数据
VTR
| Resident fees and services | $1.3B | 78% |
| Outpatient medical and research portfolio | $230.1M | 14% |
| Triple-net leased properties | $123.1M | 7% |
| Third-party capital management revenues | $4.4M | 0% |
